The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species B Gruhne, R Sompallae, D Marescotti, SA Kamranvar, S Gastaldello, ... Proceedings of the National Academy of Sciences 106 (7), 2313-2318, 2009 | 291 | 2009 |
A lung/liver-on-a-chip platform for acute and chronic toxicity studies D Bovard, A Sandoz, K Luettich, S Frentzel, A Iskandar, D Marescotti, ... Lab on a Chip 18 (24), 3814-3829, 2018 | 153 | 2018 |
A framework for in vitro systems toxicology assessment of e-liquids AR Iskandar, I Gonzalez-Suarez, S Majeed, D Marescotti, A Sewer, ... Toxicology Mechanisms and Methods 26 (6), 392-416, 2016 | 92 | 2016 |
In Vitro Systems Toxicology Assessment of a Candidate Modified Risk Tobacco Product Shows Reduced Toxicity Compared to That of a Conventional Cigarette I Gonzalez-Suarez, F Martin, D Marescotti, E Guedj, S Acali, S Johne, ... Chemical research in toxicology 29 (1), 3-18, 2016 | 86 | 2016 |
An intestine-on-a-chip model of plug-and-play modularity to study inflammatory processes L Gijzen, D Marescotti, E Raineri, A Nicolas, HL Lanz, D Guerrera, ... SLAS TECHNOLOGY: Translating Life Sciences Innovation 25 (6), 585-597, 2020 | 60 | 2020 |
IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity L Lattanzi, C Rozera, D Marescotti, G D’Agostino, L Santodonato, ... Immunobiology 216 (5), 537-547, 2011 | 51 | 2011 |
Biological impact of cigarette smoke compared to an aerosol produced from a prototypic modified risk tobacco product on normal human bronchial epithelial cells U Kogel, IG Suarez, Y Xiang, E Dossin, PA Guy, C Mathis, D Marescotti, ... Toxicology in Vitro 29 (8), 2102-2115, 2015 | 43 | 2015 |
Systems Biology Approach for Evaluating the Biological Impact of Environmental Toxicants in Vitro I Gonzalez-Suarez, A Sewer, P Walker, C Mathis, S Ellis, H Woodhouse, ... Chemical research in toxicology 27 (3), 367-376, 2014 | 37 | 2014 |
The biological effects of long-term exposure of human bronchial epithelial cells to total particulate matter from a candidate modified-risk tobacco product M van der Toorn, A Sewer, D Marescotti, S Johne, K Baumer, D Bornand, ... Toxicology in Vitro 50, 95-108, 2018 | 34 | 2018 |
Application of a multi-layer systems toxicology framework for in vitro assessment of the biological effects of Classic Tobacco e-liquid and its corresponding aerosol using an e … AR Iskandar, F Zanetti, D Marescotti, B Titz, A Sewer, A Kondylis, P Leroy, ... Archives of Toxicology 93 (11), 3229-3247, 2019 | 33 | 2019 |
High content screening analysis to evaluate the toxicological effects of harmful and potentially harmful constituents (HPHC) D Marescotti, IG Suarez, S Acali, S Johne, A Laurent, S Frentzel, J Hoeng, ... JoVE (Journal of Visualized Experiments), e53987, 2016 | 28 | 2016 |
In Vitro Systems Toxicology Assessment of Nonflavored e-Cigarette Liquids in Primary Lung Epithelial Cells I Gonzalez-Suarez, D Marescotti, F Martin, E Scotti, E Guedj, S Acali, ... Applied In Vitro Toxicology 3 (1), 41-55, 2017 | 23 | 2017 |
Inhibition of Serine‐Peptidase Activity Enhances the Generation of a Survivin‐Derived HLA‐A2‐Presented CTL Epitope in Colon‐Carcinoma Cells G Preta, D Marescotti, C Fortini, P Carcoforo, C Castelli, M Masucci, ... Scandinavian Journal of Immunology 68 (6), 579-588, 2008 | 23 | 2008 |
How complex should an in vitro model be? Evaluation of a complex 3D alveolar model with transcriptomic data and computational biological network models D Marescotti, T Serchi, K Luettich, Y Xiang, E Moschini, M Talikka, ... ALTEX-Alternatives to animal experimentation 36 (3), 388-402, 2019 | 19 | 2019 |
Systems toxicology assessment of a representative e-liquid formulation using human primary bronchial epithelial cells D Marescotti, C Mathis, V Belcastro, P Leroy, S Acali, F Martin, R Dulize, ... Toxicology reports 7, 67-80, 2020 | 18 | 2020 |
Proteasome inhibitors induce the presentation of an Epstein–Barr virus nuclear antigen 1‐derived cytotoxic T lymphocyte epitope in Burkitt’s lymphoma cells F Destro, F Sforza, M Sicurella, D Marescotti, E Gallerani, A Baldisserotto, ... Immunology 133 (1), 105-114, 2011 | 17 | 2011 |
In vitro systems toxicology-based assessment of the potential modified risk tobacco product CHTP 1.2 for vascular inflammation-and cytotoxicity-associated mechanisms promoting … C Poussin, A Laurent, A Kondylis, D Marescotti, M van der Toorn, E Guedj, ... Food and Chemical Toxicology 120, 390-406, 2018 | 16 | 2018 |
High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation G Coppotelli, N Mughal, D Marescotti, MG Masucci Journal of Biological Chemistry 286 (22), 19565-19575, 2011 | 15 | 2011 |
Development of an Advanced Multicellular Intestinal Model for Assessing Immunomodulatory Properties of Anti-Inflammatory Compounds D Marescotti, G Lo Sasso, D Guerrera, K Renggli, PA Ruiz Castro, ... Frontiers in Pharmacology 12, 639716, 2021 | 13 | 2021 |
Characterization of an human leucocyte antigen A2‐restricted Epstein–Barr virus nuclear antigen‐1‐derived cytotoxic T‐lymphocyte epitope D Marescotti, F Destro, A Baldisserotto, M Marastoni, G Coppotelli, ... Immunology 129 (3), 386-395, 2010 | 13 | 2010 |